Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Investigating patient acceptability of stratified medicine for schizophrenia : a mixed methods study

Tools
- Tools
+ Tools

Jilka, Sagar, Odoi, Clarissa Mary, Meran, Sazan, MacCabe, James H and Wykes, Til (2021) Investigating patient acceptability of stratified medicine for schizophrenia : a mixed methods study. Schizophrenia Bulletin Open, 2 (1). sgab016. doi:10.1093/schizbullopen/sgab016 ISSN 2632-7899.

[img]
Preview
PDF
sgab016.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons: Attribution-Noncommercial 4.0.

Download (146Kb) | Preview
Official URL: http://dx.doi.org/10.1093/schizbullopen/sgab016

Request Changes to record.

Abstract

Background
Health services have advocated a stratified medicine approach in mental health, but little is known about whether service users would accept this approach.

Aims
To explore service users’ views of the acceptability of stratified medicine for treatment-resistant schizophrenia compared to the traditional “trial-and-error” approach.

Methods
A mixed methods observational study that explored questionnaire responses on acceptability and whether these responses were affected by demographic or clinical variables. We also investigated whether treatment responsiveness or experience of invasive tests (brain scans and blood tests) affected participants’ responses. Questionnaire generated qualitative data were analyzed thematically. Participants (N108) were aged 18–65, had a diagnosis of schizophrenia, and were adherent to antipsychotic medication.

Results
Acceptability of a stratified approach was high, even after participants had experienced invasive tests. Most rated it as safer (62% vs 43%; P < .01 [CI: −1.69 to 2.08]), less risky (77% vs 44%; P < .01 [CI: −1.75 to 1.10]), and less painful (90% vs 73%; P < 0.01 [CI: −0.84 to 0.5]) and this was not affected by treatment responsiveness or test experience. Although not statistically significant, treatment nonresponders were more willing to undergo invasive tests. Qualitatively, all participants raised concerns about the risks, discomfort, and potential side effects associated with the invasive tests.

Conclusions
Service users were positive about a stratified approach for choosing treatments but were wary of devolving clinical decisions to purely data-driven algorithms. These results reinforce the value of service user perspectives in the development and evaluation of novel treatment approaches.

Item Type: Journal Article
Subjects: R Medicine > R Medicine (General)
R Medicine > RA Public aspects of medicine
R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Mental health -- Treatment , Schizophrenia -- Treatment, Mentally ill -- Patients -- Treatment, Evidence-based medicine , Personalized medicine , Biochemical markers
Journal or Publication Title: Schizophrenia Bulletin Open
Publisher: Oxford University Press
ISSN: 2632-7899
Official Date: 10 May 2021
Dates:
DateEvent
10 May 2021Published
Volume: 2
Number: 1
Article Number: sgab016
DOI: 10.1093/schizbullopen/sgab016
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 4 March 2022
Date of first compliant Open Access: 4 March 2022
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
IS-BRC-1215-20018NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Researchhttp://dx.doi.org/10.13039/100014461
IS-BRC-1215-20018South London and Maudsley NHS Foundation Trusthttp://dx.doi.org/10.13039/100009362
MR/L011794/1[MRC] Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
Is Part Of: 1

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us